Literature DB >> 20546500

Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider.

I H Bahcecioglu1, C Aygun, N Gozel, O K Poyrazoglu, Y Bulut, M Yalniz.   

Abstract

Hepatitis delta virus (HDV) is a serious cause of liver-related morbidity and mortality. Coexistent infection with HDV tends to aggravate the course of hepatitis B virus (HBV)-associated liver disease. The aim of this study was to determine the prevalence of HDV infection among patients chronically infected with HBV in the Elazig region, which is in eastern Turkey. A group of 282 patients infected with chronic HBV were investigated for the study. Anti-HDV seropositivity was evaluated in all patients. The anti-HDV-positive patients were further tested for HDV RNA. Severity of liver disease was assessed by liver biopsy. Regression analysis was used to determine the relationship between independent variables and HDV positivity. Of 282 chronic HBV patients, 192 were men (68.1%) and 90 were women (31.9%). The mean age was 43.8 ± 12.7 (between 18 and 73 years). Anti-HDV was positive in 45.5% of the patients (128/282). Among the 128 anti-HDV-positive patients, 116 were checked for HDV RNA and 56.9% were found positive (66/116). Chronic HDV infection rate was therefore present in at least 23.4% of the whole study group (66/282). There were 83 patients with cirrhosis (29.4%) in the study group. Anti-HDV seroprevalence and HDV RNA presence were higher in those with cirrhosis (61.4% and 42.2%, respectively). No significant relationship was found between anti-HDV seropositivity and demographic factors such as age, sex and operation or transfusion history except family history. HDV-RNA-positive patients had significantly higher ALT and lower albumin levels when compared to HDV-RNA-negative patients. HDV-RNA-positive patients also had a significantly higher fibrosis stage. In conclusion, these findings demonstrated that HDV infection is endemic and still a serious problem in the Elazig region of eastern Turkey. HDV infection is significantly related to the family exposure and increases the risk of severe liver fibrosis in this region.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546500     DOI: 10.1111/j.1365-2893.2010.01329.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  13 in total

Review 1.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

2.  Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes.

Authors:  Tatyana Kushner; Marina Serper; David E Kaplan
Journal:  J Hepatol       Date:  2015-05-08       Impact factor: 25.083

Review 3.  Hepatitis D Virus: Introduction and Epidemiology.

Authors:  Mario Rizzetto
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

4.  Hepatitis D infection: from initial discovery to current investigational therapies.

Authors:  Ben L Da; Theo Heller; Christopher Koh
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-23

5.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2022-04-01

6.  Molecular epidemiology of hepatitis B virus infection in Switzerland: a retrospective cohort study.

Authors:  Cédric Hirzel; Gilles Wandeler; Marta Owczarek; Meri Gorgievski-Hrisoho; Jean-Francois Dufour; Nasser Semmo; Samuel Zürcher
Journal:  BMC Infect Dis       Date:  2015-10-30       Impact factor: 3.090

7.  Inactıve hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study.

Authors:  Nese Demirturk; Tuna Demirdal
Journal:  Clin Mol Hepatol       Date:  2014-03-26

8.  The prevalence and impact of brucellosis in patients with hepatitis delta virus infection: inside the Brucella outbreak with cirrhosis.

Authors:  Burak Suvak; Ahmet Cumhur Dulger; Ozlem Suvak; Aysun Özel Yesilyurt; Bilge Gultepe; Huseyin Guducuoglu
Journal:  Arch Med Sci       Date:  2017-01-20       Impact factor: 3.318

Review 9.  Hepatitis delta virus: a peculiar virus.

Authors:  Carolina Alves; Cristina Branco; Celso Cunha
Journal:  Adv Virol       Date:  2013-10-02

10.  Anti-HDV seroprevalance among patients with previous HBV infection.

Authors:  Abdurrahman Sahin; Suzan Gurocak; Nurettin Tunc; Ulvi Demirel; Orhan Kursat Poyrazoglu; Handan Akbulut; Mehmet Yalniz; Zulal Asci Toraman; Ibrahim Halil Bahcecioglu
Journal:  North Clin Istanb       Date:  2018-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.